Daptomycin for the treatment of gram-positive infections after cardiac surgery

被引：0
|
作者：
Luchting, B. [1 ]
Weis, F. [1 ]
Heyn, J. [1 ]
Beiras-Fernandez, A. [2 ,3 ]
机构：
[1] Klinikum Univ Munchen, Klin Anaesthesiol, Munich, Germany
[2] Klinikum Univ Munchen, Herzchirurg Klin & Poliklin, Munich, Germany
[3] Klinikum Johann Wolfgang Goethe Univ, D-60590 Frankfurt, Germany
来源：
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2013年 / 108卷 / 01期
关键词：
Gram-positive Infections; Daptomycin; Cardiac surgery; Resistences; Efficacy; RESISTANT STAPHYLOCOCCUS-AUREUS; MAJOR HEART-SURGERY; POSTOPERATIVE MEDIASTINITIS; CLINICAL-EVIDENCE; JOINT INFECTIONS; VANCOMYCIN; THERAPY; ENDOCARDITIS; BACTEREMIA; PATIENT;
D O I：
10.1007/s00063-012-0163-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background and method. Surgical infection remains a main cause of death after heart surgery, despite advances in pharmacological therapy. Daptomycin is a cyclic lipopeptide antibiotic, useful in gram-positive organisms resistant to standard treatment, including vancomycin. The aim of this study was to describe the use of daptomycin regarding efficacy, efficiency and safety in patients with gram-positive infections after heart surgery using a retrospective analysis on 49 adult patients. Conclusion. Daptomycin shows excellent in vitro and in vivo activity against gram-positive organisms, such as Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, especially MRSA. Daptomycin is also effective against increasing vancomycin-resistant or vancomycin-intermediate S. aureus.
引用
收藏
页码：59 / 62
页数：4
相关论文
共 50 条
  • [41] Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update
    Balice, Giuseppe
    Passino, Claudio
    Bongiorni, Maria Grazia
    Segreti, Luca
    Russo, Alessandro
    Lastella, Marianna
    Luci, Giacomo
    Falcone, Marco
    Di Paolo, Antonello
    ANTIBIOTICS-BASEL, 2022, 11 (07):
  • [42] Newer developments in the treatment of Gram-positive infections
    Koomanachai, Pornpan
    Crandon, Jared L.
    Nicolau, David P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (17) : 2829 - 2843
  • [43] The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections
    Jugun, Kheeldass
    Vaudaux, Pierre
    Garbino, Jorge
    Pagani, Leonardo
    Hoffmeyer, Pierre
    Lew, Daniel
    Uckay, Ilker
    INTERNATIONAL ORTHOPAEDICS, 2013, 37 (07) : 1375 - 1380
  • [44] High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
    Kullar, Ravina
    Davis, Susan L.
    Levine, Donald P.
    Zhao, Jing J.
    Crank, Christopher W.
    Segreti, John
    Sakoulas, George
    Cosgrove, Sara E.
    Rybak, Michael J.
    PHARMACOTHERAPY, 2011, 31 (06): : 527 - 536
  • [45] The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections
    Kheeldass Jugun
    Pierre Vaudaux
    Jorge Garbino
    Leonardo Pagani
    Pierre Hoffmeyer
    Daniel Lew
    Ilker Uçkay
    International Orthopaedics, 2013, 37 : 1375 - 1380
  • [46] Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients
    Chaftari, Anne-Marie
    Hachem, Ray
    Mulanovich, Victor
    Chemaly, Roy F.
    Adachi, Javier
    Jacobson, Kalen
    Jiang, Ying
    Raad, Issam
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (02) : 182 - 186
  • [47] Treatment of Gram-positive left-sided infective endocarditis with daptomycin
    Kaya, Selcuk
    Yilmaz, Gurdal
    Kalkan, Ahmet
    Ertunc, Baris
    Koksal, Iftihar
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (04) : 698 - 702
  • [48] Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin
    Lundstrom, TS
    Sobel, JD
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (03) : 651 - +
  • [49] Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections
    Abdel-Rahman, Susan M.
    Benziger, David P.
    Jacobs, Richard F.
    Jafri, Hasan S.
    Hong, Erica Fischer
    Kearns, Gregory L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (04) : 330 - 334
  • [50] Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis
    Boulekbache, Abdelwahab
    Maldonado, Fanny
    Kavafian, Raphael
    Ferry, Tristan
    Bourguignon, Laurent
    Goutelle, Sylvain
    Lega, Jean-Christophe
    Garreau, Romain
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (04) : 712 - 721
12345